3 Drug Companies Fall on Zantac Lawsuit Fears. It Shows the Power of Analysts. - Barron's

Sanofi, GSK, and Haleon had big market drops for two straight days after UBS weighed in with a downgrade of Sanofi.

Shares of Sanofi GSK and Haleon  fell for the second straight trading session Thursday on surging worries about litigation over Zantac, a heartburn drug that the Food and Drug Administration … [+412 chars]

full article...